Drug reference
lugol solution
ionic inhibitor, antithyroid drug (iodine preparation) · antithyroid, radiation protection
ionic inhibitor, antithyroid drug (iodine preparation)antithyroid, radiation protection
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Consists of 5% iodine and 10% potassium iodide, yielding about 8 mg of iodine per drop. Provides iodide that acutely reduces the secretion and synthesis of thyroid hormone.
Indications
preoperative period in preparation for thyroidectomyin conjunction with antithyroid drugs and propranolol in the treatment of thyrotoxic crisisprotection from radioactive iodine fallout
Dosing
- Adult
- 16 to 36 mg (2–6 drops) three times a day.
Contraindications
- pregnancy
Side effects
Common
iodism (unpleasant brassy taste, burning in the mouth and throat, soreness of the teeth and gums, increased salivation, coryza, sneezing, irritation of the eyes with swelling of the eyelids, mild iodism simulates a "head cold", enlarged and tender parotid and submaxillary glands, skin lesions, gastric irritation, diarrhea, fever, anorexia, depression)
Serious
- angioedema
- laryngeal edema (may lead to suffocation)
- multiple cutaneous hemorrhages
- serum sickness type of hypersensitivity (fever, arthralgia, lymph node enlargement, eosinophilia)
- thrombotic thrombocytopenic purpura
- fatal periarteritis nodosa
- severe and sometimes fatal eruptions (ioderma)
Related guidelines
Other ionic inhibitor, antithyroid drug (iodine preparation) drugs
Ask House about lugol solution
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team